Care pathways for people with major depressive disorder
Introduction Major depressive disorder (MDD) is a leading cause of disability worldwide, in part due to its high prevalence and high rates of comorbidities, recurrence, chronicity and treatment-resistance. These indicate that MDD is treated suboptimally despite a multitude of effective interventi...
Main Authors: | R. Strawbridge, A. Young |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2022-06-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933822015875/type/journal_article |
Similar Items
-
Care pathways, prescribing practices and treatment outcomes in major depressive disorder and treatment-resistant depression: retrospective, population-based cohort study
by: Sofia Pappa, et al.
Published: (2024-01-01) -
Neuroinflammatory Hypothesis in Major Depressive Disorder
by: Gulfizar Sozeri-Varma
Published: (2014-02-01) -
Recent advance in autophagy-related pathways and key biomarkers in major depressive disorder
by: LI Siyuan, et al.
Published: (2023-10-01) -
Peripheral tryptophan and serotonin and kynurenine pathways in major depression: A case-control study
by: R. Colle, et al.
Published: (2021-04-01) -
Real-world assessment of treatment inertia in the management of patients treated for major depressive disorder in the USA
by: John J Sheehan, et al.
Published: (2023-11-01)